News

Healio14h
FDA clears phase 2 trial of immunoglobulin eye drops in dry eye disease
The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...
Ophthalmology Times19h
FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Clinical Trials Arena on MSN22h
FDA clears Grifols’ application for dry eye disease treatment
The US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase ...